TAG:

dna test

Go to a Football Game, Get a Free Genetic Test!

GENETIC TESTS REPLACED BOBBLEHEAD DOLLS AS THE GIVEAWAY at yesterday’s Baltimore Ravens home game against the Cleveland Browns. That’s a first in the world of professional sports! Tens of thousands of football fans received a fee DNA test kit as they entered the stadium on Sunday. The event was …

Read More



February 29, 2016 Intelligence: Late Breaking Lab News

Sandy, Utah-based Sure Genomics is the latest genetic testing company to get a letter from the Food and Drug Administration asking why the company is marketing its SureDNA genetic testing kit to consumers without first obtaining clearance from the federal agency. Th…

Read More



Pathology Labs Want Method To Correct Specimen ID Errors

CEO SUMMARY: When pathology labs discover instances of a misidentified or contaminated tissue specimen, there is a new service that allows them to retrospectively use DNA to properly match that specimen to the correct patient. In part two of our series, we look at how some pathology labs …

Read More



New Business Helps Reduce Pathology Specimen ID Errors

CEO SUMMARY: Prevention of diagnostic testing errors is getting more attention by both physicians and pathology labs because patients are less tolerant of potentially life-changing errors. Strand Diagnostics’ Know Error system is designed to reduce or eliminate errors involving tissue s…

Read More



Med Tech Finds “Grace” Aboard Lab of Mercy Ship

CEO SUMMARY: One intrepid medical technologist has spent almost two decades in volunteer service working in the clinical laboratories of hospital ships operated by Mercy Ships International. As the world’s largest hospital ship, the Africa Mercy contains six operating rooms, a 78-bed IC…

Read More



December 19, 2011 “Intelligence: Late Breaking Lab News”

Expanded genetic testing for cancer patients in the United Kingdom is one goal of a new effort by the Stratified Medicine Programme at Cancer Research UK. Officials want to ensure that the right genetic tests are available to support use of new therapeutic drugs for …

Read More



In-Practice Histology Lab Splits Biopsies; ID’s Patient with DNA

In response to continuing requests by clients and readers of THE DARK REPORT, this issue institutes a new feature titled “Lab Fraud Watch.” It will provide information about activities in the medical laboratory testing marketplace which could be interpreted as violatin…

Read More



TriPath Imaging and Ventana Sign Major Development Pact

IF THE NEW BUSINESS AGREEMENT between Ventana Medical Systems, Inc. and TriPath Imaging, Inc. is successful, then the anatomic pathology laboratory may have a very different look in future years. Last week, Ventana Medical Systems, Inc. announced a …

Read More



Digene, Kaiser Northern California, ARUP Labs, Bio-Reference Labs, Specialty Labs

DIGENE ENJOYS GROWTH OF 39% IN RECENT MONTHS FUELED BY RECOGNITION that HPV plays a key role in causing cervical cancer, demand for Digene Corporation’s hc2 High-Risk HPV DNA test is increasing at impressive rates. For fiscal third quarter 2004, Digene reported revenue gr…

Read More



HPV Test Volume Grows With Payer Acceptance

CEO SUMMARY: Because cervical cancer screening involves more than 55 million Pap tests per year in the United States, it is a high-profile segment of the lab testing industry. HPV testing is making steady inroads into the cervical cancer screening process. Digene Corporation is the direct…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.